Literature DB >> 8038014

Are streptokinase antibodies clinically important?

M B Buchalter.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8038014      PMCID： PMC1025264          DOI： 10.1136/hrt.70.2.101

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  7 in total

1.  Antistreptokinase titres after intravenous streptokinase.

Authors:  S Jalihal; G K Morris
Journal:  Lancet       Date:  1990-01-27       Impact factor: 79.321

2.  Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction.

Authors:  H D White; D B Cross; B F Williams; R M Norris
Journal:  Br Heart J       Date:  1990-09

3.  Thrombolytic therapy with streptokinase using a standard dosage scheme.

Authors:  M Verstraete; J Vermylen; A Amery; C Vermylen
Journal:  Br Med J       Date:  1966-02-19

4.  Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous streptokinase and anistreplase in acute myocardial infarction.

Authors:  R Fears; J Hearn; R Standring; J L Anderson; V J Marder
Journal:  Am Heart J       Date:  1992-08       Impact factor: 4.749

5.  Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG.

Authors:  R Fears; H Ferres; E Glasgow; R Standring; K J Hogg; J D Gemmill; J M Burns; A P Rae; F G Dunn; W S Hillis
Journal:  Br Heart J       Date:  1992-08

6.  Immunoglobulin response to intravenous streptokinase in acute myocardial infarction.

Authors:  M Lynch; W A Littler; B L Pentecost; R A Stockley
Journal:  Br Heart J       Date:  1991-08

7.  Streptokinase resistance: when might streptokinase administration be ineffective?

Authors:  M B Buchalter; G Suntharalingam; I Jennings; C Hart; R J Luddington; R Chakraverty; S K Jacobson; P L Weissberg; T P Baglin
Journal:  Br Heart J       Date:  1992-11
  7 in total
  5 in total

1.  A rapid agglutination assay to detect anti-streptokinase antibodies.

Authors:  J P McRedmond; N T Mulvihill; M Kane; B Burke; B Aloul; T Forde; M Walsh; D J Fitzgerald
Journal:  Ir J Med Sci       Date:  2004 Oct-Dec       Impact factor: 1.568

Review 2.  Criteria for drug usage review of thrombolytics in acute myocardial infarction.

Authors:  S McGlynn
Journal:  Pharmacoeconomics       Date:  1995-01       Impact factor: 4.981

3.  Are streptokinase antibodies clinically important?

Authors:  M Lynch; W A Littler; B L Pentecost; R A Stockley
Journal:  Br Heart J       Date:  1994-03

4.  Streptokinase antibodies are of clinical importance and they can be measured in half an hour by a simple enzyme-linked immunosorbent assay.

Authors:  J Brügemann; J van der Meer; V J Bom; K I Lie
Journal:  Br Heart J       Date:  1994-08

5.  Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS--A Novel Therapeutic Opportunity.

Authors:  Lena Winstedt; Sofia Järnum; Emma Andersson Nordahl; Andreas Olsson; Anna Runström; Robert Bockermann; Christofer Karlsson; Johan Malmström; Gabriella Samuelsson Palmgren; Ulf Malmqvist; Lars Björck; Christian Kjellman
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.